Version 2 2023-03-27, 09:42Version 2 2023-03-27, 09:42
Version 1 2023-03-27, 09:39Version 1 2023-03-27, 09:39
journal contribution
posted on 2023-03-27, 09:42authored byTara Chand, Sarah Alizadeh, Hamidreza Jamalabadi, Luisa Herrmann, Marina Krylova, Galina Surova, Johan van der Meer, Gerd Wagner, Veronika Engert, Martin Walter
This is a plain language summary of a published peer-reviewed article. It refers to a clinical trial demonstrating effects of the natural medication Neurexan in reducing hypervigilance, a form of hyperactivation in the resting brain after a stressful situation. This summary was not peer-reviewed but it represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please read the full open-access article online.